{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:03:59Z","timestamp":1790370239146,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymgme.2026.110255","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:36:56Z","timestamp":1787931416000},"page":"110255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma and urinary NMR metabolic profiling of the phenylalanine-tyrosine pathway in nitisinone-treated alkaptonuria: comparison of two dosing regimens and identification of a candidate pharmacodynamic biomarker"],"prefix":"10.1016","volume":"149","author":[{"given":"Daniela","family":"Grasso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Balloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mazzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Iacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Peruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Frediani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bernini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110255_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-024-00498-x","article-title":"Alkaptonuria","volume":"10","author":"Bernardini","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymgme.2026.110255_bb0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/TACG.S186773","article-title":"Alkaptonuria: current perspectives","volume":"13","author":"Zatkova","year":"2020","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.ymgme.2026.110255_bb0015","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/S0140-6736(01)41972-6","article-title":"The incidence of alkaptonuria: a study in chemical individuality","volume":"160","author":"Garrod","year":"1902","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2026.110255_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(01)78482-6","article-title":"The Croonian lectures on inborn errors of metabolism","volume":"172","author":"Garrod","year":"1908","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2026.110255_bb0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0021-9258(18)70560-7","article-title":"The nature of the defect in tyrosine metabolism in alcaptonuria","volume":"230","author":"La Du","year":"1958","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110255_bb0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng1093-201","article-title":"Homozygosity mapping of the gene for Alkaptonuria to chromosome 3q2","volume":"5","author":"Pollak","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2026.110255_bb0035","article-title":"Alkaptonuria","volume":"1","author":"Mistry","year":"2013","journal-title":"Rare Dis."},{"key":"10.1016\/j.ymgme.2026.110255_bb0040","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa021736","article-title":"Natural history of Alkaptonuria","volume":"347","author":"Phornphutkul","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2026.110255_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/ODRR.S92995","article-title":"Nitisinone: a review","volume":"7","author":"Aktuglu-Zeybek","year":"2017","journal-title":"Orphan Drugs Res. Rev."},{"key":"10.1016\/j.ymgme.2026.110255_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.taap.2006.01.015","article-title":"Tyrosinemia produced by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) in experimental animals and its relationship to corneal injury","volume":"215","author":"Lock","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ymgme.2026.110255_bb0055","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","article-title":"Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase","volume":"340","author":"Lindstedt","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2026.110255_bb0060","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S2213-8587(20)30228-X","article-title":"Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial","volume":"8","author":"Ranganath","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ymgme.2026.110255_bb0065","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s100240010146","article-title":"Tyrosinemia: a review","volume":"4","author":"Russo","year":"2001","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.ymgme.2026.110255_bb0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00003495-200666060-00002","article-title":"Nitisinone in the treatment of hereditary tyrosinaemia type 1","volume":"66","author":"McKiernan","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.ymgme.2026.110255_bb0075","article-title":"Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria","volume":"30","author":"Ranganath","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110255_bb0080","series-title":"Tyrosinemia Type Il, Encyclopedia of Molecular Mechanisms of Disease","first-page":"2132","author":"Raj","year":"2009"},{"key":"10.1016\/j.ymgme.2026.110255_bb0085","first-page":"1","article-title":"Reversible keratopathy due to hypertyrosinaemia following intermittent low-dose nitisinone in alkaptonuria: a case report","volume":"17","author":"Stewart","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2026.110255_bb0090","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-014-0457-0","article-title":"The role of nitisinone in tyrosine pathway disorders","volume":"16","author":"Lock","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ymgme.2026.110255_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0014-5793(81)80333-X","article-title":"Tyrosine aminotransferase as the rate-limiting step for tyrosine catabolism in isolated rat liver cells","volume":"127","author":"Dickson","year":"1981","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2026.110255_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415805","article-title":"Untargeted NMR metabolomics reveals alternative biomarkers and pathways in alkaptonuria","volume":"23","author":"Grasso","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.110255_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26199674","article-title":"Ochronotic deposition in alkaptonuria: semiquinone-mediated oxidative coupling and metabolic drivers of homogentisic acid accumulation","volume":"26","author":"Grasso","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2026.110255_bb0110","doi-asserted-by":"crossref","first-page":"22562","DOI":"10.1038\/s41598-021-01670-z","article-title":"A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria","volume":"11","author":"Bernini","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2026.110255_bb0115","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1039\/C9AN01005J","article-title":"Reliable, high-quality suppression of NMR signals arising from water and macromolecules: application to bio-fluid analysis","volume":"144","author":"Aguilar","year":"2019","journal-title":"Analyst"},{"key":"10.1016\/j.ymgme.2026.110255_bb0120","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1021\/acs.analchem.7b02354","article-title":"Alternatives to nuclear Overhauser enhancement spectroscopy Presat and Carr-Purcell-Meiboom-Gill Presat for NMR-based metabolomics","volume":"89","author":"Le Guennec","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ymgme.2026.110255_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2022.114826","article-title":"An improved NMR approach for metabolomics of intact serum samples","volume":"654","author":"Grasso","year":"2022","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2026.110255_bb0130","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0001-2998(83)80043-9","article-title":"Principles of nuclear magnetic resonance for medical application","volume":"13","author":"Rosen","year":"1983","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.ymgme.2026.110255_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9070123","article-title":"NMR spectroscopy for metabolomics research","volume":"9","author":"Emwas","year":"2019","journal-title":"Metabolites"},{"issue":"11","key":"10.1016\/j.ymgme.2026.110255_bb0140","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/nprot.2007.376","article-title":"Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts","volume":"2","author":"Beckonert","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymgme.2026.110255_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.698337","article-title":"Nuclear magnetic resonance spectroscopy in clinical metabolomics and personalized medicine: current challenges and perspectives","volume":"8","author":"Letertre","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymgme.2026.110255_bb0150","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/annrheumdis-2014-206033","volume":"75","author":"Ranganath","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ymgme.2026.110255_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12100927","article-title":"Comprehensive biotransformation analysis of Phenylalanine-Tyrosine metabolism reveals alternative routes of metabolite clearance in Nitisinone-treated Alkaptonuria","volume":"12","author":"Norman","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.ymgme.2026.110255_bb0160","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nature04648","article-title":"Pharmaco-metabonomic phenotyping and personalized drug treatment","volume":"440","author":"Clayton","year":"2006","journal-title":"Nature"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922600538X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922600538X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:35:52Z","timestamp":1790368552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671922600538X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S109671922600538X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110255","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma and urinary NMR metabolic profiling of the phenylalanine-tyrosine pathway in nitisinone-treated alkaptonuria: comparison of two dosing regimens and identification of a candidate pharmacodynamic biomarker","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110255"}}